News

Catheter Precision's Impressive Q2 Growth and Innovations

Catheter Precision's Impressive Q2 Growth and Innovations

Remarkable Financial Growth in Second Quarter

Catheter Precision, Inc. (VTAK), a prominent US medical device company, recently reported significant operational results for the second quarter of 2025. Known for its innovative solutions in the cardiac electrophysiology sector, the company’s advancements are noteworthy for stakeholders and potential investors alike.

Sales Surge and Revenue Highlights

This quarter marked a remarkable increase in revenue, with product sales climbing an impressive 128% compared to Q2 2024. The momentum continues, as the first half of 2025 also saw a 103% increase in revenue relative to the same period last year. Sequentially, the company achieved a noteworthy 48% rise in sales quarter-over-quarter.

Market Expansion with CE Mark

In a significant achievement, Catheter Precision received the coveted CE Mark for its LockeT product. With this approval, sales are anticipated to commence in Europe during the third quarter, broadening the company’s market reach significantly.

Clinical Data Breakthroughs at Industry Symposium

Another highlight for Catheter Precision this quarter was the presentation of groundbreaking clinical data at the annual Heart Rhythm Society symposium. These presentations underscored not just the efficacy of their products but also the invaluable insights gained from recent studies.

Key Clinical Findings

The studies presented revealed:

  • **Accuracy and Long-Term Outcomes:** A multi-center study involving 125 patients demonstrated that VIVO achieved over 94% accuracy in mapping and could enhance long-term outcomes with procedural success rates exceeding 83%.
  • **Three-Dimensional Mapping Innovation:** A study focusing on difficult-to-map premature ventricular contractions showed how VIVO can improve mapping effectiveness and lead to successful ablation outcomes.
  • **LockeT's Efficacy:** Research confirmed the safety and effectiveness of LockeT in procedures requiring large-bore access sites, essential for new treatments like leadless pacemakers.
  • **VT Mapping Accuracy:** A trailblazing study indicated that VIVO’s mapping system predicts exit site locations with an 89% accuracy, crucial for tailored patient treatment paths.

Strategic Developments in Cardionomix

In a move to further strengthen its position in the market, Catheter Precision completed the acquisition of Cardionomic's heart failure assets, solidifying its commitment to innovation. Furthermore, the establishment of Kardionav, Inc., a joint venture focused on developing an implant-based software product, is poised to enhance therapeutic precision for treating ventricular tachyarrhythmias.

Financial Standing and Future Outlook

As of June 30, 2025, Catheter Precision reported total assets of $25.6 million, with shareholders' equity reaching $6.5 million. Revenues for Q2 were approximately $212 thousand, a striking increase from the previous year's $93 thousand for the same quarter. However, the company reported a net loss of approximately $5.4 million for the quarter.

CEO's Perspective on Recent Achievements

David Jenkins, CEO of Catheter Precision, expressed enthusiasm regarding the company's growth trajectory, stating that both sales and clinical advancements are indicative of rising market recognition and demand for their products, especially with the expanding international reach facilitated by the LockeT's CE Mark. The positive momentum is expected to foster enhanced operations in the coming quarters, reflecting the solid commitment to innovation and market presence.

About Catheter Precision and Its Innovations

Catheter Precision is dedicated to improving cardiac arrhythmia treatments through its pioneering technologies. With products like LockeT, a suture retention device designed for wound closure following venous punctures, and VIVO, a non-invasive 3D imaging system, Catheter Precision continues to lead in advancing cardiac procedures. Both products have received essential regulatory approvals, ensuring they meet the high standards of safety and efficacy required in medical environments.

Frequently Asked Questions

What is Catheter Precision, Inc. known for?

Catheter Precision, Inc. specializes in developing advanced medical devices for the cardiac electrophysiology market, focusing on innovative solutions to improve patient care.

How much did Catheter Precision's revenue increase in Q2 2025?

The company reported a 128% increase in revenue from product sales compared to Q2 2024.

What new market approval did Catheter Precision receive recently?

Catheter Precision received the CE Mark for its LockeT product, allowing sales to begin in Europe.

What were the net losses reported by Catheter Precision for Q2 2025?

The company recorded a net loss of approximately $5.4 million for the quarter.

How is Catheter Precision expanding its product offerings?

The acquisition of Cardionomic's assets and the formation of Kardionav, Inc. marks significant steps towards enhancing their product portfolio.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 143

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
Subaru's 650-Car Anniversary Bet Is Delightfully Small

Updated Category News Views 31

Gold brake calipers may sound like a fussy correction, yet that little detail tells you exactly who Subaru is trying to please. The company has revised its announcement for the 2027 WRX tS GD25 and BRZ tS ZC15, clarifying the anniversary-model names and changing the WRX description from red-painted to gold-painted Brembo calipers. Nobody should confuse a corrected paint...

Continue Reading
Albany Masonry Waterproofing Is a Quiet Value Play

Updated Category News Views 92

Winter works its mischief one soaked brick at a time. That is the unglamorous truth behind Sean Mulligan's discussion of masonry waterproofing for Albany-area homes. Brick and stone look tough enough to outlast the furniture, the siding, maybe the whole neighborhood. Yet they are porous materials, and in a region where rain, snowmelt, and sharp temperature swings keep...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 81

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
Italian Wine Faces U.S. Slump and New Market Openings

Updated Category News Views 110

American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....

Continue Reading
BetterInvesting Puts ELMD and FIVE Under a Fresh Lens

Updated Category News Views 74

Two familiar market traps are hiding in this otherwise useful announcement: mistaking a study candidate for a buy signal, and treating the word undervalued like it fell from a mountaintop. BetterInvesting has named Electromed Inc. as its “Stock to Study” and Five Below Inc. as its “Undervalued Stock” for the January-February 2027 issue of its magazine. That is...

Continue Reading
Three Cash Buyouts Draw Fresh Shareholder Scrutiny

Updated Category News Views 168

Three cash-price tags landed on the tape with a lawyerly asterisk attached: are public holders actually getting a fair shake? On November 18, 2026, Halper Sadeh LLC said it was investigating proposed sales involving Surgery Partners, Braze and CCC Intelligent Solutions. That is not a finding of misconduct, and investors ought to keep that distinction bolted firmly to the...

Continue Reading
Layne’s Jacksonville Debut Tests East Texas Expansion

Updated Category News Views 15

Jacksonville is not some flashy coastal launch, and that is precisely why this Layne’s Chicken Fingers opening matters. A new chicken tender shop at 1217 S. Jackson St. will not move public markets, because this is a franchise-growth story rather than a ticker story. But it does offer a clean look at whether Layne’s can turn its Texas roots into a durable multi-market...

Continue Reading
Hanmi Compressor Tests Vietnam Before Wider Expansion

Updated Category News Views 91

Compressed air is the sort of factory necessity nobody brags about until it fails, and that is precisely why Hanmi Compressor’s Vietnam plan deserves a sober look. The Daegu-based specialist is not arriving with a grand export victory lap. It is still building the front door: a website, a promotional video, and a process for finding Vietnamese manufacturers and...

Continue Reading
Hexaware’s Seven-Year Client Signal Is Worth Watching

Updated Category News Views 195

Seven straight years of recognition is harder to shrug off than one shiny plaque on a corporate shelf. Hexaware Technologies announced on November 18, 2026 that it received the ISG Star of Excellence Award in the Client Champion category, marking its seventh consecutive year of recognition in that awards program. For investors following IT services, that is a...

Continue Reading

Top 5 Most Recently Viewed Articles

Penske's Q3 2026: Revenue Up, Private Deal Awaits

Updated Category News Views 189

Jumping straight into it, Penske Automotive Group (NYSE: PAG) just rolled out their quarterly numbers. The highlights? A 5% revenue bump, landing at $8.4 billion. That's nice, sure, but let's not get too cozy, there's a bigger elephant in this garage—it's the bold move to take the company private! Our old friend volatility still sends shivers down the spine of long-time...

Continue Reading
Shanghai Hosts 20th Global Entrepreneurship Week

Updated Category News Views 226

Shanghai: A Hacker's Paradise of Innovation? The heart of financial ambition beats loud and clear in Shanghai this time of year. November 10 to 14, 2026, promises to be a spectacle of entrepreneurial valor as the city hosts the 20th Global Entrepreneurship Week China. This isn't just some run-of-the-mill networking shindig; we're talking about over 50 dazzling events,...

Continue Reading
Strategic Merger of BerGenBio and Oncoinvent Bolsters Growth

Updated Category News Views 247

BerGenBio and Oncoinvent Proposed Merger Overview In a significant development within the biotechnology sector, BerGenBio ASA and Oncoinvent ASA have announced their plans for a merger. The merger aims to combine both companies into a single entity with BerGenBio as the acquiring company, fostering a collaborative approach to advancing innovative cancer therapies. Details...

Continue Reading
Cloud-Native Application Protection Platform Market Sees Surge

Updated Category News Views 89

Cloud-Native Application Protection Platform Market Surge The Cloud-Native Application Protection Platform (CNAPP) market is witnessing remarkable growth, recently reported to be nearly $700 million in the second quarter of 2024. This represents a staggering 42 percent increase year-over-year. The recent findings emphasize how companies are prioritizing cloud security as...

Continue Reading
Arkay Zero Proof's Bold Move with $6 Million Times Square Launch

Updated Category News Views 319

Arkay Zero Proof Takes Times Square by Storm with Major Campaign Arkay Zero Proof, known for its innovative non-alcoholic spirits, is making headlines with a bold advertising initiative in the bustling Times Square. With a remarkable investment of $6 million, this campaign aims to enhance Arkay's brand visibility while reinforcing its position in the thriving market of...

Continue Reading